Trump officials weigh Fox News regular for FDA vaccine regulator post
TL;DR Summary
The Trump administration is weighing Houman Hemmati, an ophthalmologist and entrepreneur who frequently appears on Fox News, to lead the FDA’s Center for Biologics Evaluation and Research (CBER) over vaccines and treatments for complex diseases; no final decision has been made, and Hemmati would replace Vinay Prasad, who is stepping down, with reported support from FDA Commissioner Marty Makary.
- Trump officials consider physician, a Fox News regular, for top vaccine post The Washington Post
- Exclusive: FDA narrows in on search for new biologics and vaccines leader Endpoints News
- FDA Vaccine Post Candidate Is Fox News Regular, Frequent Newsom Critic Bloomberg.com
- Landmines await Vinay Prasad’s successor at the FDA statnews.com
- Potential Leadership Change at FDA Could Affect Dyne Therapeutics (DYN) GuruFocus
Reading Insights
Total Reads
0
Unique Readers
22
Time Saved
19 min
vs 20 min read
Condensed
98%
3,913 → 59 words
Want the full story? Read the original article
Read on The Washington Post